GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
2.360
-0.250 (-9.58%)
At close: Mar 20, 2026, 4:00 PM EDT
2.400
+0.040 (1.69%)
After-hours: Mar 20, 2026, 7:11 PM EDT
GRI Bio Market Cap
GRI Bio has a market cap or net worth of $3.41 million as of March 20, 2026. Its market cap has decreased by -4.28% in one year.
Market Cap
3.41M
Enterprise Value
-4.75M
1-Year Change
-4.28%
Ranking
Category
Stock Price
$2.36
Market Cap Chart
Since April 24, 2023, GRI Bio's market cap has decreased from $25.29M to $3.41M, a decrease of -86.51%. That is a compound annual growth rate of -49.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 3.41M | 36.53% |
| Dec 31, 2025 | 2.50M | -66.25% |
| Dec 31, 2024 | 7.40M | 326.73% |
| Dec 29, 2023 | 1.73M | -93.14% |
| Apr 24, 2023 | 25.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genprex | 4.66M |
| Revelation Biosciences | 4.54M |
| Bio Green Med Solution | 4.46M |
| Aptevo Therapeutics | 4.37M |
| Silo Pharma | 4.26M |
| Indaptus Therapeutics | 4.19M |
| Matinas BioPharma Holdings | 3.81M |
| Aspire Biopharma Holdings | 3.51M |